Enhanced cell cycle entry and mitogen-activated protein kinase-signaling and downregulation of matrix metalloproteinase-1 and -3 in human diabetic arterial vasculature

Atherosclerosis

Volumn 195, Issue 1, 2007, Pages e1-

  Chung, Ada W Y ^a,b,c   Luo, Honglin ^a   Tejerina, Teresa ^d   van Breemen, Cornelis ^a,b,c   Okon, Elena B ^a,c  

^a The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d SCHOOL OF MEDICINE   (Spain)

Author keywords

Cell cycle; Diabetes mellitus; Internal mammary artery; Matrix metalloproteinase; Mitogen activated protein kinase signaling

Indexed keywords

BETA CATENIN; COLLAGEN; CYCLIN D1; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RETINOBLASTOMA PROTEIN; STROMELYSIN;

ADULT; AGED; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETIC PATIENT; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; MAMMARY ARTERY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 35248821731     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.01.011     Document Type: Article

References (30)

1. Hurst R.T., and Lee R.W. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 139 (2003) 824-834
2. Kornowski R., Mintz G.S., Kent K.M., et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 95 (1997) 1366-1369
3. Ruiz E., Gordillo-Moscoso A., Padilla E., et al. Human vascular smooth muscle cells from diabetic patients are resistant to induced apoptosis due to high bcl-2 expression. Diabetes 55 (2006) 1243-1251
4. Bruemmer D., and Law R.E. Thiazolidinedione regulation of smooth muscle cell proliferation. Am J Med 115 Suppl. 8A (2003) 87S-92S
5. Feliers D., Frank M.A., and Riley D.J. Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy. Diabetes 51 (2002) 3290-3299
6. Okon E.B., Chung A.W., Rauniyar P., et al. Compromised arterial function in human type 2 diabetic patients. Diabetes 54 (2005) 2415-2423
7. Wang X., Xiao Y., Mou Y., et al. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 90 (2002) 340-347
8. Indolfi C., Torella D., Cavuto L., et al. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 103 (2001) 2980-2986
9. Campbell M., Allen W.E., Silversides J.A., and Trimble E.R. Glucose-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase-dependent upregulation of the platelet-derived growth factor-beta receptor potentiates vascular smooth muscle cell chemotaxis. Diabetes 52 (2003) 519-526
10. McCawley L.J., and Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 13 (2001) 534-540
11. Suzuki L.A., Poot M., Gerrity R.G., and Bornfeldt K.E. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 50 (2001) 851-860
12. Moreno P.R., Fallon J.T., Murcia A.M., et al. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients. J Am Coll Cardiol 34 (1999) 1045-1049
13. Jacob M.P., Badier-Commander C., Fontaine V., et al. Extracellular matrix remodeling in the vascular wall. Pathol Biol 49 (2001) 326-332
14. Faries P.L., Rohan D.I., Takahara H., et al. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg 33 (2001) 601-607
15. Cohen P. The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction. Philos Trans R Soc Lond B Biol Sci 354 (1999) 485-495
16. Wagman A.S., Johnson K.W., and Bussiere D.E. Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes. Curr Pharm Des 10 (2004) 1105-1137
17. Uglow E.B., Slater S., Sala-Newby G.B., et al. Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res 92 (2003) 1314-1321
18. Otero K., Martinez F., Beltran A., et al. Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J 359 (2001) 567-574
19. Frame S., and Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359 (2001) 1-16
20. Wang S., Nath N., Minden A., and Chellappan S. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J 18 (1999) 1559-1570
21. Guo J., Sheng G., and Warner B.W. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells. J Biol Chem 280 (2005) 35992-35998
22. Jacob A., Molkentin J.D., Smolenski A., Lohmann S.M., and Begum N. Insulin inhibits PDGF-directed VSMC migration via NO/cGMP increase of MKP-1 and its inactivation of MAPKs. Am J Physiol Cell Physiol 283 (2002) C704-C713
23. Gratton J.P., Morales-Ruiz M., Kureishi Y., et al. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 276 (2001) 30359-30365
24. Taniyama Y., Morishita R., Hiraoka K., et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation 104 (2001) 2344-2350
25. Cheng J.C., Chou C.H., Kuo M.L., and Hsieh C.Y. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25 (2006) 7009-7018
26. Ehling A., Schaffler A., Herfarth H., et al. The potential of adiponectin in driving arthritis. J Immunol 176 (2006) 4468-4478
27. Yoshida N., Okumura K., and Aso Y. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 54 (2005) 345-350
28. Koyama H., Raines E.W., Bornfeldt K.E., Roberts J.M., and Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87 (1996) 1069-1078
29. Murato K., and Motoyama T. Collagen species in various sized human arteries and their changes with intimal proliferation. Artery 17 (1990) 96-106
30. Sansilvestri-Morel P., Rupin A., Jullien N.D., et al. Decreased production of collagen Type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3. J Vasc Res 42 (2005) 388-398